By Maureen McArthur
~
Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate
in Physiology/Medicine will give the William R. Martin Visiting Professor Lecture
entitled "Cellular Signaling with Nitric Oxide and Cyclic GMP" at 3 p.m.
Thursday, April 29, 1999, in the UK Hospital auditorium (HG-611).
~
|
LEXINGTON, KY (April 21, 1999) – The
graduate students of the Department of Pharmacology, University of Kentucky College of
Medicine, have invited Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate in
Physiology/Medicine to give the William R. Martin Visiting Professor Lecture entitled
"Cellular Signaling with Nitric Oxide and Cyclic GMP" at 3 p.m. Thursday, April
29, 1999, in the UK Hospital auditorium (HG-611). Murad and his colleagues received the
Nobel Prize for their discovery that nitric oxide, a colorless and odorless gas, lowers
blood pressure by acting as a signal to blood vessels to relax and widen. This property of
nitric oxide has applications ranging from treatment of heart disease to reducing the
possibility of pulmonary hypertension, a life-threatening condition in premature babies.
For more than 30 years, Murad has been cited for advancing the understanding of
biochemical mechanisms in numerous cell types and tissues, including the roles of cyclic
GMP and nitric oxide.
Active in both academic medicine and the pharmacological industry throughout his
career, Murad has been president and chief executive officer at Molecular Geriatrics
Corporation and vice president of research and development at Abbott Laboratories and held
academic positions at the University of Virginia School of Medicine and Stanford
University. He is currently the John S. Dunn Sr. Distinguished Professor and chair of the
Department of Integrative Biology, Pharmacology and Physiology at The University of
Texas-Houston Health Science Center.
For more information, call 323-8032. |
